theMednetRegister

Gynecologic Cancers

Cancer Prevention   

Questions discussed in this category

When, if ever, would you recommend risk reducing BSO in patients with moderate penetrance breast cancer germline mutations?
Genes such as ATM, CHEK2, PALB2, RAD51C/D, BRIP1 seem to show some potential increased risk of ovarian cancer. Should these patients under prophylacti...
2 Answers available

Related Topics in Gynecologic Cancers

Copyright © 2024 theMednet
All Rights Reserved.